Home / Germany / Nemus Bioscience, Inc.
Nemus Bioscience, Inc.
Short position disclosed on August 25, 2026.
0.54% of the capital sold short
1 disclosing fund
3 disclosures on record
US83086J3095 ISIN code
Evolution of the disclosed total
0%0.5%1%1.5%
Aug 31Sep 6Sep 12Sep 18Sep 24
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Arrowstreet Capital, Limited Partnership | 0.54% | unchanged | August 25, 2026 |
In the United States SKYE (Nasdaq): 128,781 shares sold short on August 31, 2026. FINRA names no fund.
Get the moves on Nemus Bioscience, Inc. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 3, 2026 | Squarepoint Ops LLC | 0.60% | |
| August 25, 2026 | Squarepoint Ops LLC | 0.55% | |
| August 25, 2026 | Arrowstreet Capital, Limited Partnership | 0.54% | still open |
Download 3 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Germany
- HelloFresh SE 7.90% of the capital sold short
- AUTO1 Group SE 7.29% of the capital sold short
- TUI AG 6.65% of the capital sold short
- Hugo Boss AG 6.02% of the capital sold short
- Velo3D Inc 5.85% of the capital sold short
- PVA TePla AG 5.72% of the capital sold short
- K+S Aktiengesellschaft 5.50% of the capital sold short
- Puma SE 5.49% of the capital sold short
- RENK Group AG 5.43% of the capital sold short
- Zalando SE 5.39% of the capital sold short
- Ocean Power Technologies, Inc 5.22% of the capital sold short
- Gamesquare Holdings, Inc. 5.02% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Nemus Bioscience, Inc., source Bundesanzeiger, data as at August 25, 2026, https://www.quivad.com/action/nemus-bioscience-inc